A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource

August 2022 Medicare Drug List Updates: Thirty-three (33) medications added to the 2022 Medicare Part D Drug plan formularies.

Category: Monthly Formulary Changes
Published: Aug, 13 2022 10:08:01

The August 2022 Medicare Part D prescription drug plan formulary (drug list) data is now online and included in our Formulary Browser and Q1Rx Drug Finder.

The August formulary updates include the addition of 39 new National Drug Codes (NDCs), representing 33 different prescription drugs, many with multiple strengths.

The formulary updates impact both stand-alone Medicare Part D plans (PDPs) and Medicare Advantage plans with drug coverage (MAPDs).

Highlights of the August 2022 Formulary updates include six (6) newly-added brand-name drugs

The August drug data updates include eighteen (18) new brand-name drugs, six (6) of which are newly introduced brand-name drugs, some with multiple strengths. These drugs include:
  • TWYNEO®, and
  • ZIMHI®.

The August 2022 Formulary updates include two (2) newly-added generic drugs

The August Medicare Part D drug data also includes fifteen (15) new generic medications, two (2) of which are newly-introduced generic drugs.  These new generic drugs include:

Please note that these new generic and brand-name drugs are not available on all Medicare Part D or Medicare Advantage drug plans - and you can review the chart to see the (often limited) number of plan formularies that now include these drugs.

Reminders about Medicare prescription drug plan formulary changes
  1. Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan.

  2. Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

Good to know: What is the NDC?

The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: https://Q1FAQ.com/155.html

Summary of August 2022 NDC changes

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 39 new August 2022 NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 1
New Drug 15
New Drug and Strength 6
New Drug, Delivery Form and Strength 1
New Manufacturer 1
New Manufacturer and Strength 2
New Packaging 1
New Strength 12
Grand Total 39

The following chart details the 39 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates -- as you will notices, some drugs are only covered by a few Medicare plans.

You can click on the Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) and see the details of how this drug is covered by all Medicare Part D plans (PDPs) in Florida (our example state).  You can then change the state in our search form for details of drug coverage in your service area.

NDC Drug Name Number of
PDP Formularies*
Number of
MAPD Formularies*
62332054460ASENAPINE 2.5 MG TABLET SUBLIGUAL [Saphris]63396New Strength
52817082445BETAMETHASONE DP 0.05% OINTMENT [Maxivate]54392New Drug
00781718675BRIMONIDINE-TIMOLOL 0.2%-0.5% DROPS [Combigan]33205New Drug
42227008301CINRYZE 500 UNIT VIAL-DILUENT37255New Drug
00378876091CYCLOSPORINE 0.05% EYE EMULS DROPERETTE [Restasis]8154New Drug
54482002002CYSTARAN 0.44% EYE DROPS63398New Drug
00054071119DEFERIPRONE 1,000 MG TABLET (3X/DY) [Ferriprox]18253New Manufacturer and Strength
00074732513DEPAKOTE DR 125 MG TABLET DR21New Strength
00074732713DEPAKOTE DR 500 MG TABLET DR21New Strength
00074740213DEPAKOTE ER 500 MG TABLET ER 24H22New Strength
24979070306DEXLANSOPRAZOLE DR 30 MG CAPSULE BP [Kapidex]17146New Drug and Strength
24979070406DEXLANSOPRAZOLE DR 60 MG CAPSULE BP [Kapidex]17146New Drug and Strength
00093094801DICLOFENAC POT 50 MG TABLET [Cataflam]60384New Drug
24338002603EVEKEO 10 MG TABLET03New Strength
24338002203EVEKEO 5 MG TABLET03New Strength
68180074506FENOFIBRATE 30 MG CAPSULE [Antara]032New Strength
69315028109FENOFIBRIC ACID DR 45 MG CAPSULE [Trilipix]30285New Manufacturer and Strength
00904718861HYDROCORTISONE 10 MG TABLET [Hydrocortone]63403New Drug
52427066130LOREEV XR 1.5 MG CAPSULE ER 24H03New Strength
00121082501MORPHINE SULF 100 MG/5 ML CONC SOLUTION [Roxanol-T]52385New Drug
00169477212OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN INJCTR53352New Strength
00378456105POTASSIUM CL ER 10 MEQ TABLET [Klotrix]63398New Manufacturer
75052000101PREHEVBRIO 10 MCG/ML VIAL58376New Drug
43598034901PROGESTERONE 100 MG CAPSULE [Prometrium]46314New Drug and Strength
59651015301PROGESTERONE 200 MG CAPSULE [Prometrium]46314New Drug and Strength
10122050201REVCOVI 2.4 MG/1.5 ML VIAL39168New Drug
00074104328RINVOQ ER 45 MG TABLET ER 24H58390New Strength
66869056490SEGLENTIS 56 MG-44 MG TABLET01New Drug
71770010560SIKLOS 100 MG TABLET070New Drug and Strength
71770012030SIKLOS 1,000 MG TABLET072New Drug and Strength
72205005976SILDENAFIL 10 MG/ML ORAL SUSPENSION [Revatio]785New Drug, Delivery Form and Strength
47783064601TAKHZYRO 300 MG/2 ML SYRINGE2168New Delivery Form
49702025837TRIUMEQ PD 60-5-30 MG TABLET SUSP63403New Drug
00299594530TWYNEO 0.1%-3% CREAM (G)01New Drug
72336091079VALSARTAN 4 MG/ML SOLUTION25New Drug
49884094499VARENICLINE STARTING MONTH BOX TABLET DS PK [Chantix]54370New Packaging
24338085303ZENZEDI 10 MG TABLET2583New Strength
24338085103ZENZEDI 5 MG TABLET2583New Strength
78670014002ZIMHI 5 MG/0.5 ML SYRINGE2105New Drug

Our online Formulary Browser and Drug Finder

You can review any Medicare plan formulary using the Q1Medicare.com Formulary Browser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.